ReviewJournal of gynecologic oncology2022
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies.
Rowan E Miller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled itcites it